IndraLab

Statements

Sphingosine-1-phosphocholine inhibits IKBKB. 1 / 1

| 1

reach

"Celgene has developed a series of quinazoline analogues including a molecule termed SPC 839, which inhibits IKKbeta with an IC50 of 62 nM and has been shown to reduce paw oedema in a rat arthritis mod[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

18308615

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Sphingosine-1-phosphocholine inhibits IKBKB. 1 / 1

INDRA sources:

Databases

Reading